Warning Issued by FDA about Levemir Insulin

A recent press release announced that 129,000 vials of the long-acting insulin Levemir, were recently stolen and are being sold in the United States. Because it is unknown whether the stolen insulin was stored and handled properly, the FDA has issued a warning to consumers using this product. There has been one reported case of an adverse reaction to the insulin in these stolen vials.

Health officials are asking consumers who use Levemir to check their insulin to see if it contains the lot number XZF0036, XZF0037 or XZF0038. The lot number is located on the side of the box of insulin and also on the side of the vials. If you find that you have insulin from one of these lots, you are asked to not use it and return it to the pharmacy for a new vial.

Additional questions can be directed to the manufacturer, Novo Nordisk Inc., at 800-727-6500.

Learn more about storing insulin, insulin therapy and insulin delivery devices.